Boston Scientific Corporation vs Tyson Foods, Inc. — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Tyson Foods, Inc. trades at $56.25 (market cap $19.85B). The key difference: Boston Scientific Corporation is far larger — about 3.7× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays a 3.62% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | TSN | |
|---|---|---|
Market Cap | $74.19B | $19.85B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $68.75 |
52-Week Low | $42.63 | $50.72 |
Enterprise Value | $86.27B | $27.12B |
Dividend Yield | — | 3.62% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →